'In the following review, we perform a synthesis of the different types of tumor antigens now being targeted with TCR-T cell therapy in the clinic and new promising antigens developed at the preclinical stage.'
https://www.science.org/doi/10.1126/sciadv.adf3700#.Y-1cGIGJPoE.linkedin